1 Memorial Sloan-Kettering Cancer Center and Weill Cornell ...

More documents

Recommendations

Info

5/18/2011 “Adoptive Therapy of Cancer with T cells Genetically Targeted to TumorAssociated Antigens through the Introduction of Chimeric Antigen Receptors(CARs): Trafficking, Persistence, and Perseverance”, American Society of Geneand Cell Therapy 14 th Annual Meeting, Seattle, WA6/1/2011 “Adoptive Therapy of Cancer using Genetically Targeted T cells: EnhancingCAR design, preclinical studies, translation to the clinical setting, and addressingthe tumor microenvironment", Preston Robert Tisch Brain Tumor Center Seminar,Duke University, Durham, NC10/19/2011 “Adoptive T-cell Therapy of Cancer from the Bench Top to the Bedside andBeyond”, 2 nd Annual Asian Cellular Therapy Organization, Miyazaki, Japan10/21/2011 “Genetically Modified T cells for Cancer Therapy: Building the Perfect T cell”,National Cancer Center, Tokyo, Japan12/21/2011 “Adoptive therapy of B cell malignancies with genetically targeted T cells: Fromthe bench top to the bedside and back again”, Dana-Farber Cancer Institute,Boston, MA2/24/2012 “Chimeric Antigen Receptors (CARs): Adoptive therapy of B cell malignanciesutilizing CD19 targeted CAR modified T cells” Keynote Lecture, 16 th AnnualInternational Congress on Hematologic Malignancies, Snowbird, UT3/18/2012 “Adoptive Cell Therapy: Utilizing the Immune System to combat Cancer” &“Genetically Targeted T cells in Cancer Immunotherapy: the past, the present, andthe future”, Innovations in Oncology – Targeted Therapies and Cancer Program,Delhi, India4/13/2012 “Adoptive Therapy of Cancer of Cancer using Tumor Targeted T-cells: A GeneticApproach, Medical Grand Rounds at Roswell Park Cancer Institute, Buffalo, NY6/2/2012 Discussant, Poster Discussion Session – Developmental Therapeutics-ClinicalPharmacology and Immunotherapy Track, American Society of ClinicalOncology 48 th Annual Meeting, Chicago, IL6/6/2012 “Clinical Translation of an Adoptive Therapeutic Approach to Cancer: Obstaclesfrom the Perspective of an Academic Investigator”, International Society of CellTherapy 18 th Annual Meeting, Seattle, WA6/8/2012 “Chimeric Antigen Receptor (CAR) modified T cells as a novel approach toimmuno-therapy of B cell malignancies”, International Society of Cell Therapy18 th Annual Meeting, Seattle, WA9/9/2012 “CAR modified T cell therapy: Future directions and moving beyond the singlecenter setting”, 10 th International Workshop on Non-Hodgkin Lymphoma,Boston, MA12
10/19/2012 “Chimeric antigen receptor (CAR) modified T cells as a novel approach to cancerimmunotherapy: Initial promising clinical responses and future directions”,Japanese Society of Hematology 74 th Annual Meeting, Kyoto, Japan11/7/2012 “Treatment of Cancer with Genetically Modified T-cells”, ChemotherapyFoundation Symposium on Innovative Cancer Therapy for Tomorrow,Hematology Session, Mount Sinai School of Medicine, New York, NY11/27/2012 “Chimeric Antigen Receptor Expressing T cells (CARETS): A CurativeImmunotherapy Platform for Adoptive T Cell Therapy of Cancer”, NYCEmerging Technologies Summit, New York, New York12/8/2012 “Novel Cellular Therapies for Leukemia: CAR-Modified T-Cells Targeted to theCD19 Antigen”, American Society of Hematology 54 th Annual Meeting, Atlanta,Georgia12/21/2012 “CAR Modified T-Cells and Cancer Therapy”, Memorial Sloan-Kettering CancerCenter Medicine Grand Rounds, New York, NY2/14/2013 “Adoptive Therapy of Cancer with Genetically Modified T Cells”, 4 th AnnualConference on Cancer Biologics part of Cambridge Healthtech Institute’s 20 thInternational Molecular Medicine Tri-Conference, San Francisco, CaliforniaEditorial responsibilitiesJournal name (ad hoc reviewer vs Editorial Board with position as applicable)Journal Reviewer:BloodJournal of Clinical InvestigationJournal of Clinical OncologyJournal of ImmunologyCancer Immunology and ImmunotherapyCancer ResearchClinical Cancer ResearchClinical LeukemiaMolecular TherapyGene TherapyAmerican Journal of HematologyExperimental HematologyBMC ImmunologyPLoS ONEPNASNature Reviews Clinical OncologyHaematologicaEuropean Journal of Immunology13
Page 1 and 2: Memorial Sloan-Kettering Cancer Cen
Page 3 and 4: 3. Hospital positions (e.g., attend
Page 5 and 6: Kendrick Kelly History Scholar 1988
Page 7 and 8: Sarwish Rafiq PhD; Role: Post Doc F
Page 9 and 10: Experimental Therapeutics Center Pr
Page 11: 3/29/2009 “Adoptive T cell therap
Page 15 and 16: L. BIBLIOGRAPHY1. Brentjens RJ, Spi
Page 17 and 18: 1. Books, book chapters and reviews
Page 19 and 20: 11. R. Brentjens, E. Santos, R. Yeh
Page 21 and 22: 35. M.L. Davila, C.Taylor, X.Wang,
Page 23: 56. E. Halton, D. Chung, K. Xiao, H

1 Memorial Sloan-Kettering Cancer Center and Weill Cornell ...

Create successful ePaper yourself

Delete template?

Save as template?